Table 3.
Logistic regression analysis on the risk factors of GDM in patients with PCOS.
| Unadjusted | Adjusted | |||||
| Variables | OR | 95%CI | P | OR | 95%CI | P |
| Age ≥30 yrs | 5.124 | 3.081–7.224 | .042 | 2.418 | 1.181–3.784 | .032 |
| BMI ≥24 kg/m2 | 3.118 | 2.143–5.125 | .012 | 1.973 | 1.266–3.121 | .021 |
| HOMA-IR ≥22.69 | 4.233 | 1.768–6.007 | .024 | 2.491 | 1.193–4.043 | .015 |
| Fins ≥22.71 mIU/L | 3.741 | 2.125–6.225 | .016 | 2.508 | 1.166–5.057 | .022 |
| Testosterone ≥2.85 nmol/L | 2.217 | 1.206–4.166 | .039 | 1.821 | 1.104–2.762 | .013 |
| Androstenedione ≥6.63 nmol/L | 3.102 | 2.147–5.124 | .017 | 1.954 | 1.262–2.844 | .046 |
| SHBG <64.22 nmol/L | 2.197 | 1.284–3.179 | .025 | 1.497 | 1.028–2.016 | .039 |